ArticleOncology letters2022

Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors.

Adrián A Negreros-Osuna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.